应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AMRX Amneal Pharmaceuticals, Inc.
盘后交易 10-29 19:30:44 EDT
21.35
+0.21
+0.99%
盘后
21.35
+0.00
0.00%
19:30 EDT
最高
21.65
最低
21.11
成交量
440.02万
今开
21.51
昨收
21.14
日振幅
2.55%
总市值
68.11亿
流通市值
40.78亿
总股本
3.19亿
成交额
9,390万
换手率
2.30%
流通股本
1.91亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
安美制药收获里程碑:FDA正式批准Lanreotide注射剂120mg/0.5ml预充式无菌单剂量注射器
美股速递 · 09-19
安美制药收获里程碑:FDA正式批准Lanreotide注射剂120mg/0.5ml预充式无菌单剂量注射器
Amneal Pharmaceuticals 将定期贷款转为20.4亿美元,并新增4520万美元贷款——SEC文件披露
美股速递 · 08-04
Amneal Pharmaceuticals 将定期贷款转为20.4亿美元,并新增4520万美元贷款——SEC文件披露
Amneal Pharmaceuticals获美国FDA批准新增浓度与剂型,进一步扩展碘海醇注射液产品组合
美股速递 · 07-17
Amneal Pharmaceuticals获美国FDA批准新增浓度与剂型,进一步扩展碘海醇注射液产品组合
美国FDA启动预审试点项目,安尼尔、Cellares、礼来、富士胶片等多家企业参与
美股速递 · 06-30
美国FDA启动预审试点项目,安尼尔、Cellares、礼来、富士胶片等多家企业参与
Zambon与Amneal宣布Hopledo® (ipx203)获欧盟CHMP正面评价,用于治疗帕金森病伴中重度运动波动成人患者
美股速递 · 06-29
Zambon与Amneal宣布Hopledo® (ipx203)获欧盟CHMP正面评价,用于治疗帕金森病伴中重度运动波动成人患者
Amneal公布Elevate-Pd研究全部受试者中期4期结果,进一步证实Crexont®在帕金森病中的既定疗效
美股速递 · 06-05
Amneal公布Elevate-Pd研究全部受试者中期4期结果,进一步证实Crexont®在帕金森病中的既定疗效
异动解读 | AMRX盘中大跌8.65% 利润增长放缓引发对未来获利能力担忧
异动解读 · 2025-02-28
异动解读 | AMRX盘中大跌8.65% 利润增长放缓引发对未来获利能力担忧
Amneal Pharmaceuticals(AMRX.US):2024年Q4财报实现营收7.305亿美元,前值为6.17亿美元,预期值为7.081亿美元;每股收益为0.12美元,前值为0.14美元,预期值为0.15美元。
金融界 · 2025-02-28
Amneal Pharmaceuticals(AMRX.US):2024年Q4财报实现营收7.305亿美元,前值为6.17亿美元,预期值为7.081亿美元;每股收益为0.12美元,前值为0.14美元,预期值为0.15美元。
Amneal制药公司2024年第四季度调整后每股收益$0.12,低于预期$0.15,销售额$7.3052亿,超出预期$7.0755亿
财报速递 · 2025-02-28
Amneal制药公司2024年第四季度调整后每股收益$0.12,低于预期$0.15,销售额$7.3052亿,超出预期$7.0755亿
Amneal Pharmaceuticals, Inc.盘中异动 股价大涨5.16%
市场透视 · 2025-01-24
Amneal Pharmaceuticals, Inc.盘中异动 股价大涨5.16%
Amneal Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.03%
市场透视 · 2025-01-16
Amneal Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.03%
Amneal Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.02%
市场透视 · 2024-12-19
Amneal Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.02%
Amneal Pharmaceuticals, Inc.盘中异动 快速上涨5.03%报8.14美元
市场透视 · 2024-12-18
Amneal Pharmaceuticals, Inc.盘中异动 快速上涨5.03%报8.14美元
Amneal Pharmaceuticals, Inc.盘中异动 急速拉升5.02%报8.69美元
市场透视 · 2024-12-03
Amneal Pharmaceuticals, Inc.盘中异动 急速拉升5.02%报8.69美元
Amneal Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.00%报8.55美元
市场透视 · 2024-11-15
Amneal Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.00%报8.55美元
异动解读 | Amneal Pharmaceuticals股价大涨5%引发市场关注
异动解读 · 2024-11-11
异动解读 | Amneal Pharmaceuticals股价大涨5%引发市场关注
Amneal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.04%
市场透视 · 2024-11-11
Amneal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.04%
Amneal Pharmaceuticals, Inc.盘中异动 股价大跌8.25%
市场透视 · 2024-11-08
Amneal Pharmaceuticals, Inc.盘中异动 股价大跌8.25%
Amneal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.77%
市场透视 · 2024-10-01
Amneal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.77%
加载更多
公司概况
公司名称:
Amneal Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Amneal Pharmaceuticals, Inc.是特拉华州的一家公司。该公司是一家多元化的全球性生物制药企业,开发、制造、营销和分销广泛的药品组合。它通过三个部门运营:普药部门,包括零售仿制药和注射剂;特药部门,专注于中枢神经系统和内分泌疾病的品牌药;以及AvKARE部门,为美国政府及零售市场提供分销服务。
发行价格:
--
{"stockData":{"symbol":"AMRX","market":"US","secType":"STK","nameCN":"Amneal Pharmaceuticals, Inc.","latestPrice":21.35,"timestamp":1793304000000,"preClose":21.14,"halted":0,"volume":4400169,"hourTrading":{"tag":"盘后","latestPrice":21.35,"preClose":21.35,"latestTime":"19:30 EDT","volume":2039801,"amount":43549751.35,"timestamp":1793316602477,"change":0,"changeRate":0,"amplitude":0.024356},"delay":0,"changeRate":0.009933774834437126,"floatShares":191000000,"shares":318999016,"eps":0.480828,"marketStatus":"盘后交易","change":0.21,"latestTime":"10-29 19:30:44 EDT","open":21.51,"high":21.65,"low":21.11,"amount":93902092.55548501,"amplitude":0.025544,"askPrice":23.62,"askSize":100,"bidPrice":19.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.480828,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1793318400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1525665600000,"exchange":"NASDAQ","adjPreClose":21.14,"preHourTrading":{"tag":"盘前","latestPrice":21.65,"preClose":21.14,"latestTime":"09:25 EDT","volume":3581,"amount":76944.09114100001,"timestamp":1793280300044,"change":0.51,"changeRate":0.024125,"amplitude":0.107852},"postHourTrading":{"tag":"盘后","latestPrice":21.35,"preClose":21.35,"latestTime":"19:30 EDT","volume":2039801,"amount":43549751.35,"timestamp":1793316602477,"change":0,"changeRate":0,"amplitude":0.024356},"volumeRatio":0.995283,"impliedVol":0.8339,"impliedVolPercentile":0.8685},"requestUrl":"/m/hq/s/AMRX","defaultTab":"news","newsList":[{"id":"1150121097","title":"安美制药收获里程碑:FDA正式批准Lanreotide注射剂120mg/0.5ml预充式无菌单剂量注射器","url":"https://stock-news.laohu8.com/highlight/detail?id=1150121097","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150121097?lang=zh_cn&edition=full","pubTime":"2026-09-19 04:02","pubTimestamp":1789761730,"startTime":"0","endTime":"0","summary":"安美制药(Amneal Pharmaceuticals)迎来重大监管突破——美国食品药品监督管理局(FDA)已正式批准其研发的Lanreotide注射剂,规格为120mg/0.5ml,采用无菌单剂量预充式注射器包装。这一获批标志着公司在复杂仿制药及差异化产品管线布局上迈出关键一步。这款药物将有望为肢端肥大症及神经内分泌肿瘤患者提供新的治疗选择,同时也进一步完善了安美在肿瘤支持治疗领域的战略拼图。业内分析人士指出,预充式注射器设计的获批不仅提升了用药便利性,更降低了医疗机构在配制过程中的操作风险,有望在激烈的市场竞争中占据一席之地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189345955","title":"Amneal Pharmaceuticals 将定期贷款转为20.4亿美元,并新增4520万美元贷款——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1189345955","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189345955?lang=zh_cn&edition=full","pubTime":"2026-08-04 04:42","pubTimestamp":1785789728,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals 近日向美国证券交易委员会(SEC)提交文件,披露了一项重大财务调整。公司将其定期贷款转换为20.4亿美元,同时新增一笔4520万美元的定期贷款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197788574","title":"Amneal Pharmaceuticals获美国FDA批准新增浓度与剂型,进一步扩展碘海醇注射液产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1197788574","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197788574?lang=zh_cn&edition=full","pubTime":"2026-07-17 20:01","pubTimestamp":1784289675,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals, Inc.宣布,其碘海醇注射液产品组合已获得美国食品药品监督管理局(FDA)的批准,新增了多种浓度与剂型。这一批准将显著增强该公司在该造影剂市场的产品供应能力,为医疗专业人员提供更广泛的临床选择。此举不仅丰富了Amneal的产品管线,也进一步巩固了其在仿制药及专科药物领域的市场地位。公司表示,新增的规格将满足不同诊断场景下的需求,提升患者用药的可及性与灵活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113725546","title":"美国FDA启动预审试点项目,安尼尔、Cellares、礼来、富士胶片等多家企业参与","url":"https://stock-news.laohu8.com/highlight/detail?id=1113725546","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113725546?lang=zh_cn&edition=full","pubTime":"2026-06-30 04:30","pubTimestamp":1782765004,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局的“预审”试点项目迎来了一批重量级参与者。该计划旨在优化新药和疗法的审查流程,而此次加入的安尼尔制药、Cellares、礼来、富士胶片、Kriya、协和麒麟以及再生元制药等公司,无疑为项目注入了强大的行业动力。这一举措标志着FDA在推动监管科学创新、加速潜在疗法上市方面迈出了新的一步。通过让领先的制药与生物技术公司提前介入,FDA期望能更高效地识别和解决开发过程中的关键问题,从而最终惠及等待新疗法的患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0466842654.USD","LU2108987350.USD","LU1868836914.USD","LU0354030511.USD","LU2471134796.USD","LU0109391861.USD","LU1280957306.USD","SG9999015945.SGD","LU0061475181.USD","LU0889565916.HKD","LU1323610961.USD","LU2237443382.USD","LU0353189680.USD","SG9999015986.USD","LU0320765059.SGD","LU0820561909.HKD","IE00BFSS8Q28.SGD","LU2417539215.USD","LU1988902786.USD","LU2756315318.SGD","LU2746668461.USD","SG9999014880.SGD","IE00BFSS7M15.SGD","LU2552382215.SGD","LU0097036916.USD","LU0225283273.USD","LU2112291526.USD","LU2023251221.USD","LU2237443622.USD","LU0353189763.USD","BK4533","SGXZ31699556.SGD","FUJIF","LU0266013472.USD","LU1093756325.SGD","LU2236285917.USD","LU1868836591.USD","LU2324357040.USD","LU0323591593.USD","LU0198837287.USD","LU0053666078.USD","LU2265009873.SGD","IE00BJJMRX11.SGD","LU0006306889.USD","LU0158827948.USD","LU0943347566.SGD","LU2063271972.USD","SG9999015952.SGD","SGXZ57979304.SGD","GB00BDT5M118.USD","LLII","IE00BJJMRY28.SGD","LU0820562030.AUD","LU1035775433.USD","LU2237438978.USD","LU0787776722.HKD","LU2237443549.SGD","BK4007","LU1023059063.AUD","LU2746668974.SGD","LU2168564222.USD","BK4170","SGXZ81514606.USD","BK4534","LU2360106947.USD","LU2357305700.SGD","IE00B775H168.HKD","IE00BK4W5M84.HKD","LU2361044865.SGD","IE00BJJMRZ35.SGD","LU1983299246.USD","SG9999017495.SGD","LU1720051108.HKD","IE00B7KXQ091.USD","LU2089984988.USD","LU0640476718.USD","LU0471298694.HKD","LU2456880835.USD","LU2361044949.HKD","LU1804176565.USD","LU0109394709.USD","LU1232071149.USD","LU2552382132.HKD","LU0786609619.USD","REGN","IE0004445015.USD","IE00BFTCPJ56.SGD","LU2896262040.SGD","LU1548497426.USD","LU2089283258.USD","LU2237443895.HKD","LU0882574139.USD","LU1093756168.USD","SG9999015978.USD","IE00B1XK9C88.USD","LU2271345857.HKD","LU0689472784.USD","LU1127390331.HKD","IE0009355771.USD","LU2023250504.SGD","LU0256863811.USD","LU2237443465.HKD","LU1069344957.HKD","IE00B4JS1V06.HKD","LU2362541513.USD","LU2168564149.EUR","SGXZ51526630.SGD","SG9999018865.SGD","LU2361045086.USD","LU1145028129.USD","LU2750360641.GBP","LU0114720955.EUR","LU0385154629.USD","LU0471298777.SGD","LU2023250330.USD","LU0708995401.HKD","LU1623119135.USD","LU2552382058.USD","IE0002141913.USD","SG9999014914.USD","BK4599","IE00BK4W5L77.USD","BK4581","LU1057294990.SGD","LU1974910355.USD","LU2471134523.USD","BK4516","IE0005OL40V9.USD","LU0432979614.USD","LU1064131342.USD","SGXZ99366536.SGD","LLYZ","IE00B2B36J28.USD","SG9999001176.USD","LU0289739699.SGD","LU1291159041.SGD","IE00BN29S564.USD","LU0417517546.SGD","ELIL","LU2168564065.EUR","LU1814569148.SGD","LU2602419157.SGD","LU0256863902.USD","IE00BJT1NW94.SGD","LLY","LU0354030438.USD","LU1989771016.USD","SG9999013999.USD","LU0210536198.USD","LU2468319806.SGD","KYKOF","LU2362540622.SGD","LLYX","LU2028103732.USD","LU2211815571.USD","LU1629891620.HKD","LU0106261372.USD","LU1551013425.SGD","LU0823416689.USD","LU1712237335.SGD","LU0882574055.USD","LU0058720904.USD","LU1267930730.SGD","SG9999014898.SGD","LU2362541273.HKD","LU0672654240.SGD","LU0820561818.USD","LU2471134879.HKD","LU2461242641.AUD","LU0320765992.SGD","LU2462157665.USD","LU0316494557.USD","IE00B1BXHZ80.USD","SG9999018857.SGD","LU2491050071.SGD","LU0133085943.USD","LU1366192091.USD","LU2756315664.SGD","BK4139","IE00BKPKM429.USD","LU0238689110.USD","LU0823434740.USD","LU2264538146.SGD","IE0001KFT4U8.USD","LU0823434583.USD","LU1868837136.USD","ELIS","LU1868837300.USD","LU1551013342.USD","LU0683600562.USD","LU1061106388.HKD","LU2087625088.SGD","BK4585","LU0122379950.USD","LU2237443978.SGD","LU0079474960.USD","LU0158827781.USD","LU2111349929.HKD","LU2106854487.HKD","LU2750360997.AUD","SG9999001176.SGD","LU0234572021.USD","BK4588","LU2168564495.EUR","LU2168563687.JPY","LU1868836757.USD","IE0004445239.USD","LU0964807845.USD","LU0094547139.USD","SG9999014906.USD","LU2213496289.HKD","IE00BJLML261.HKD","LU1917777945.USD","AMRX","LU2471134952.CNY","LU2491050154.USD","LU0456855351.SGD","LU0203201768.USD","LU0203202063.USD","LU2089284900.SGD","LU2491049909.HKD","LU1720051017.SGD","IE00BKDWB100.SGD","IE00B4R5TH58.HKD","IE00BWXC8680.SGD","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107089082","title":"Zambon与Amneal宣布Hopledo® (ipx203)获欧盟CHMP正面评价,用于治疗帕金森病伴中重度运动波动成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1107089082","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107089082?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:03","pubTimestamp":1782716600,"startTime":"0","endTime":"0","summary":"Zambon公司与Amneal Pharmaceuticals, Inc.联合宣布,其合作研发的药物Hopledo® (ipx203)已获得欧洲药品管理局人用药品委员会(CHMP)的正面评价。该药物适用于治疗患有帕金森病并伴随中度至重度运动波动的成人患者。\n此次CHMP的积极意见是基于关键性临床试验的有利数据,表明ipx203在控制运动症状波动方面具有潜在疗效。若后续获得欧盟委员会正式批准,该疗法将为帕金森病患者提供一种新的治疗选择。\n运动波动是帕金森病进展过程中常见的并发症,可能导致患者在日常活动中经历不可预测的运动功能变化。新药的研发进展有望帮助改善这类患者的生活质量与症状管理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152014805","title":"Amneal公布Elevate-Pd研究全部受试者中期4期结果,进一步证实Crexont®在帕金森病中的既定疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1152014805","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152014805?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:01","pubTimestamp":1780660867,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals, Inc. 近日公布了其Elevate-Pd研究针对完整受试者人群的中期4期试验结果。该数据进一步强化了先前已报告的关于其药物Crexont®在治疗帕金森病方面所带来的临床获益。这些发现为该疗法的有效性和安全性提供了更全面的证据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119683393","title":"异动解读 | AMRX盘中大跌8.65% 利润增长放缓引发对未来获利能力担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1119683393","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119683393?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:59","pubTimestamp":1740754782,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals今日盘中股价大跌8.65%,引发市场广泛关注。公司近期公布的2024年第四季度财报显示,尽管销售额同比大涨18.4%至7.3052亿美元,高于市场预期,但每股收益仅为0.12美元,同比下滑14.3%,低于预期的0.15美元。利润增长乏力引发了投资者对公司未来获利能力的担忧。但投资者似乎暂时仍没有从最新财报中获得足够信心,导致AMRX股价今日承压大跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514934715","title":"Amneal Pharmaceuticals(AMRX.US):2024年Q4财报实现营收7.305亿美元,前值为6.17亿美元,预期值为7.081亿美元;每股收益为0.12美元,前值为0.14美元,预期值为0.15美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514934715","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514934715?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:11","pubTimestamp":1740741099,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals(AMRX.US):2024年Q4财报实现营收7.305亿美元,前值为6.17亿美元,预期值为7.081亿美元;每股收益为0.12美元,前值为0.14美元,预期值为0.15美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28191148462273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109132024","title":"Amneal制药公司2024年第四季度调整后每股收益$0.12,低于预期$0.15,销售额$7.3052亿,超出预期$7.0755亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1109132024","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109132024?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:09","pubTimestamp":1740740982,"startTime":"0","endTime":"0","summary":"Amneal制药公司报告季度每股收益为$0.12,比分析师一致预期的$0.15低20%。这比去年同期每股收益的$0.14减少了14.29%。公司报告季度销售额为$7.3052亿,比分析师一致预期的$7.0755亿高3.25%。以上内容来自Benzinga Earnings专栏,原文如下:Amneal Pharmaceuticals reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.15 by 20 percent. This is a 14.29 percent decrease over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $730.52 million which beat the analyst consensus estimate of $707.55 million b","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amneal制药公司2024年第四季度调整后每股收益$0.12,低于预期$0.15,销售额$7.3052亿,超出预期$7.0755亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505435070","title":"Amneal Pharmaceuticals, Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505435070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505435070?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:14","pubTimestamp":1737648855,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时14分,Amneal Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.16%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中,整体涨幅为0.19%。其相关个股中,Eton Pharmaceuticals, Inc.、阿玛琳、大自然药业涨幅较大,Inmed Pharmaceuticals Inc.、Incannex Healthcare Inc.、Painreform Ltd.较为活跃,换手率分别为18.91%、7.61%、6.74%,振幅较大的相关个股有Gelteq Limited、Inmed Pharmaceuticals Inc.、Im Cannabis Corp.,振幅分别为12.89%、12.50%、10.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001415a22d1f36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001415a22d1f36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503775996","title":"Amneal Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503775996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503775996?lang=zh_cn&edition=full","pubTime":"2025-01-16 05:00","pubTimestamp":1736974823,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日05时00分,Amneal Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.03%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中,整体涨幅为0.61%。Amneal Pharmaceuticals, Inc.公司简介:Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It also engages in the development, manufacture and sale of branded products. The company was founded in 2017 and is headquartered in Bridgewater, NJ.(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011605002398678c1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011605002398678c1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492227155","title":"Amneal Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492227155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492227155?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:03","pubTimestamp":1734552223,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时03分,Amneal Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.02%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中,整体跌幅为1.31%。其相关个股中,Scilex Holding Company C/Wts 10/11/2027 、Procaps Group S.A. C/Wts 29/09/2026 、坎伯兰药业涨幅较大,Petros Pharmaceuticals, Inc.、Quantum Biopharma Ltd.、Painreform Ltd.较为活跃,换手率分别为68.14%、28.00%、18.45%,振幅较大的相关个股有Quantum Biopharma Ltd.、Im Cannabis Corp.、Bioage Labs, Inc.,振幅分别为53.90%、37.44%、27.20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040343ab828f92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040343ab828f92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492993726","title":"Amneal Pharmaceuticals, Inc.盘中异动 快速上涨5.03%报8.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492993726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492993726?lang=zh_cn&edition=full","pubTime":"2024-12-18 01:40","pubTimestamp":1734457237,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日01时40分,Amneal Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.03%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中,整体涨幅为0.50%。其相关个股中,Petros Pharmaceuticals, Inc.、梯瓦制药、Procaps Group S.A. C/Wts 29/09/2026 涨幅较大,Petros Pharmaceuticals, Inc.、Cbdmd, Inc.、Painreform Ltd.较为活跃,换手率分别为130.66%、19.86%、12.46%,振幅较大的相关个股有Petros Pharmaceuticals, Inc.、Scilex Holding Company C/Wts 10/11/2027 、Medicus Pharma Ltd.,振幅分别为38.13%、25.00%、24.57%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218014037a1f65d9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218014037a1f65d9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488073106","title":"Amneal Pharmaceuticals, Inc.盘中异动 急速拉升5.02%报8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488073106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488073106?lang=zh_cn&edition=full","pubTime":"2024-12-03 03:02","pubTimestamp":1733166169,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日03时02分,Amneal Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.02%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中,整体涨幅为0.46%。Amneal Pharmaceuticals, Inc.公司简介:Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It also engages in the development, manufacture and sale of branded products. The company was founded in 2017 and is headquartered in Bridgewater, NJ.(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203030249a267159b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203030249a267159b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483709093","title":"Amneal Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.00%报8.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483709093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483709093?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:55","pubTimestamp":1731682555,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时55分,Amneal Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.00%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中,整体跌幅为1.92%。Amneal Pharmaceuticals, Inc.公司简介:Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It also engages in the development, manufacture and sale of branded products. The company was founded in 2017 and is headquartered in Bridgewater, NJ.(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115225555abc4f3f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115225555abc4f3f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179076959","title":"异动解读 | Amneal Pharmaceuticals股价大涨5%引发市场关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1179076959","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179076959?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:22","pubTimestamp":1731338552,"startTime":"0","endTime":"0","summary":"当日上午,制药公司Amneal Pharmaceuticals股价出现大涨行情,截至发稿时已上涨5.15%,报收9.17美元/股。这一涨幅引发了市场广泛关注。分析人士认为,这可能与该公司的基本面表现不错相关。公司最新财报显示,Amneal Pharmaceuticals营收达7.02亿美元,毛利率较高,达到38.5%。尽管净利润出现小幅亏损,但上市公司整体业绩表现优异。与此同时,当日整个制药行业股票普遍上涨,行业景气度较高也可能推动Amneal Pharmaceuticals股价走强。行业相关个股中,Sonoma Pharmaceuticals、Assertio Holdings等公司股价表现也相当出色。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482736646","title":"Amneal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482736646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482736646?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:15","pubTimestamp":1731338157,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时15分,Amneal Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.04%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中,整体涨幅为0.02%。其相关个股中,Evotec Se、Sonoma Pharmaceuticals, Inc.、Assertio Holdings, Inc.涨幅较大,Sonoma Pharmaceuticals, Inc.、Mira Pharmaceuticals, Inc.、Rockwell Medical, Inc.较为活跃,换手率分别为30.47%、2.02%、1.99%,振幅较大的相关个股有Sonoma Pharmaceuticals, Inc.、Rockwell Medical, Inc.、Mira Pharmaceuticals, Inc.,振幅分别为19.64%、11.74%、11.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111231557971a5be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111231557971a5be3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481101544","title":"Amneal Pharmaceuticals, Inc.盘中异动 股价大跌8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481101544?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:31","pubTimestamp":1731076307,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时31分,Amneal Pharmaceuticals, Inc.股票出现异动,股价快速跳水8.25%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中,整体涨幅为0.28%。其相关个股中,Alpha Teknova, Inc.、德纳维制药、基立福涨幅较大,Evoke Pharma, Inc.、Akanda Corp.、Biofrontera Inc.较为活跃,换手率分别为1.53%、1.14%、0.70%,振幅较大的相关个股有Flora Growth Corp.、Amneal Pharmaceuticals, Inc.、Cardiol Therapeutics Inc.,振幅分别为7.39%、7.32%、5.80%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822314795bdeee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822314795bdeee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2472387372","title":"Amneal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472387372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2472387372?lang=zh_cn&edition=full","pubTime":"2024-10-01 22:36","pubTimestamp":1727793398,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日22时36分,Amneal Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.77%。Amneal Pharmaceuticals, Inc.股票所在的制药行业中,整体涨幅为0.39%。其相关个股中,Flora Growth Corp.、Amneal Pharmaceuticals, Inc.、祁连国际涨幅较大,Guardion Health Sciences, Inc.、苏轩堂、大自然药业较为活跃,换手率分别为27.71%、4.72%、4.25%,振幅较大的相关个股有大自然药业、Flora Growth Corp.、Incannex Healthcare Inc.,振幅分别为17.91%、15.69%、13.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100122363998e39f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100122363998e39f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AMRX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amneal.com;investors.amneal.com","stockEarnings":[{"period":"1week","weight":0.0465},{"period":"1month","weight":0.0312},{"period":"3month","weight":0.1427},{"period":"6month","weight":0.6477},{"period":"1year","weight":1.0544},{"period":"ytd","weight":0.6778}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amneal Pharmaceuticals, Inc.是特拉华州的一家公司。该公司是一家多元化的全球性生物制药企业,开发、制造、营销和分销广泛的药品组合。它通过三个部门运营:普药部门,包括零售仿制药和注射剂;特药部门,专注于中枢神经系统和内分泌疾病的品牌药;以及AvKARE部门,为美国政府及零售市场提供分销服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.008492},{"month":2,"riseRate":0.75,"avgChangeRate":0.016211},{"month":3,"riseRate":0.375,"avgChangeRate":-0.030057},{"month":4,"riseRate":0.375,"avgChangeRate":0.004007},{"month":5,"riseRate":0.625,"avgChangeRate":0.023823},{"month":6,"riseRate":0.333333,"avgChangeRate":0.026134},{"month":7,"riseRate":0.555556,"avgChangeRate":-0.013781},{"month":8,"riseRate":0.555556,"avgChangeRate":0.027068},{"month":9,"riseRate":0.444444,"avgChangeRate":0.012446},{"month":10,"riseRate":0.777778,"avgChangeRate":0.016506},{"month":11,"riseRate":0.5,"avgChangeRate":0.037801},{"month":12,"riseRate":0.625,"avgChangeRate":0.062319}],"exchange":"NASDAQ","name":"Amneal Pharmaceuticals, Inc.","nameEN":"Amneal Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amneal Pharmaceuticals, Inc.(AMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Amneal Pharmaceuticals, Inc.(AMRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Amneal Pharmaceuticals, Inc.,AMRX,Amneal Pharmaceuticals, Inc.股票,Amneal Pharmaceuticals, Inc.股票老虎,Amneal Pharmaceuticals, Inc.股票老虎国际,Amneal Pharmaceuticals, Inc.行情,Amneal Pharmaceuticals, Inc.股票行情,Amneal Pharmaceuticals, Inc.股价,Amneal Pharmaceuticals, Inc.股市,Amneal Pharmaceuticals, Inc.股票价格,Amneal Pharmaceuticals, Inc.股票交易,Amneal Pharmaceuticals, Inc.股票购买,Amneal Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amneal Pharmaceuticals, Inc.(AMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Amneal Pharmaceuticals, Inc.(AMRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}